These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2782949)

  • 1. Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer.
    Brökelmann J; Bockisch A; Vogel J; Reinsberg J; Oehr P; Biersack HJ; Krebs D
    Arch Gynecol Obstet; 1989; 244(4):193-206. PubMed ID: 2782949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies].
    Peking A; Marinov V
    Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical immunoscintigraphy of recurrent ovarian cancer with indium 111-labeled B72.3 monoclonal antibody.
    Krag DN; Ford P; Smith L; Taylor M; Schneider PD; Bushberg JT; Goodnight JE
    Arch Surg; 1993 Jul; 128(7):819-23. PubMed ID: 8317965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoscintigraphy of oncologic tumors].
    Barzen G
    Radiol Diagn (Berl); 1990; 31(3):209-20. PubMed ID: 2367627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
    Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
    Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies].
    Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS
    Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary diagnosis and follow-up of ovarian cancer: radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and "second look".
    Barzen G; Hierholzer J; Cordes M; Friedmann W; Felix R
    Int J Rad Appl Instrum B; 1991; 18(1):69-76. PubMed ID: 2010310
    [No Abstract]   [Full Text] [Related]  

  • 8. OC125 immunoscintigraphy in ovarian carcinoma: a comparison with alternative methods of assessment.
    Maughan TS; Haylock B; Hayward M; Facey P; Evans WD; Shelley MD; Fish RG; Adams M
    Clin Oncol (R Coll Radiol); 1990 Jul; 2(4):199-205. PubMed ID: 2261415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoscintigraphy of ovarian endometriosis. A preliminary study.
    Kennedy SH; Soper ND; Mojiminiyi OA; Shepstone BJ; Barlow DH
    Br J Obstet Gynaecol; 1988 Jul; 95(7):693-7. PubMed ID: 3166379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer.
    Kudlacek S; Schieder K; Kölbl H; Neunteufel W; Nowotny C; Breitenecker G; Biegelmayer G; Vetterlein M; Fürlinger B; Micksche M
    Gynecol Oncol; 1989 Dec; 35(3):323-9. PubMed ID: 2480931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comprehensive diagnosis of cancer of the ovaries].
    Korsunskiĭ VN; Tarasenko IuI; Ostrovskaia EIu; Stupakov IA; Mironova SP
    Med Radiol (Mosk); 1989 Aug; 34(8):51-6. PubMed ID: 2549327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between 111In-labelled immunoscintigraphy and serum CA-125 levels in ovarian carcinoma patients postchemotherapy.
    Prosser ES; Pomeroy M; Barker F; Carroll K; Davis M; Duffy J; Duffy G; Fennelly JJ; O'Kennedy R
    Biochem Soc Trans; 1992 Feb; 20(1):54S. PubMed ID: 1633979
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical implications for immunoscintigraphy in patients with ovarian malignancy: a preliminary study using monoclonal antibody 791T/36.
    Symonds EM; Perkins AC; Pimm MV; Baldwin RW; Hardy JG; Williams DA
    Br J Obstet Gynaecol; 1985 Mar; 92(3):270-6. PubMed ID: 3978057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
    Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
    Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of patients with ovarian cancer using monoclonal antibodies.
    Lastoria S; Panza N; Esposito G; Vergara E; Castelli L; Caracò C; Battista C; Pacilio G; Salvatore M
    Biomed Pharmacother; 1992; 46(10):453-63. PubMed ID: 1306360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
    Göcze P; Vahrson H
    Orv Hetil; 1993 Apr; 134(17):915-8. PubMed ID: 8479736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Cannistra SA
    Gynecol Oncol; 1993 Nov; 51(2):292-4. PubMed ID: 8276314
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125.
    Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M
    Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer].
    Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A
    An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT.
    Low RN; Carter WD; Saleh F; Sigeti JS
    Radiology; 1995 May; 195(2):391-400. PubMed ID: 7724757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.